Skip to content

   Pharma Publications

Neuropsychopharmacology
  • The new normal: neural network adaptations in late-life depression
    Published on 2025-06-20
    11 months ago
  • Correction: Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing
    Published on 2025-06-18
    11 months ago
  • Medial nucleus accumbens dopamine receptors modulate motivation for wheel running in male mice
    Published on 2025-06-12
    12 months ago
  • VTA-ACC dopaminergic circuit mediates trait anxiety-related observational learning of social avoidance in male mice
    Published on 2025-06-12
    12 months ago
  • The neural and psychophysiological effects of cannabidiol in youth with alcohol use disorder: A randomized controlled clinical trial
    Published on 2025-06-11
    12 months ago
  • Prefrontal corticotropin-releasing factor promotes resilience to social stress
    Published on 2025-06-10
    12 months ago
  • Sitagliptin as a therapeutic approach for social anxiety disorder: the role of DPP4 and NPY in modulating social fear and comorbid depressive-like behavior in mice
    Published on 2025-06-09
    12 months ago
« Previous 1 … 42 43 44 45 46 … 143 Next »
Journal of Psychopharmacology
  • Acute methamphetamine and alcohol usage alters gaze behaviour during driving: A randomised, double-blind, placebo-controlled study
    Published on 2024-07-28
    2 years ago
  • Severe neutropenia unrelated to clozapine in patients receiving clozapine
    Published on 2024-07-23
    2 years ago
  • Three paradoxes related to the mode of action of pramipexole: The path from D2/D3 dopamine receptor stimulation to modification of dopamine-modulated functions
    Published on 2024-07-23
    2 years ago
  • Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity
    Published on 2024-06-21
    2 years ago
  • Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study
    Published on 2024-06-18
    2 years ago
  • Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
    Published on 2024-06-18
    2 years ago
  • Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
    Published on 2024-06-15
    2 years ago
« Previous 1 … 42 43 44 45 46 … 145 Next »
European Neuropsychopharmacology
  • Prader Willi syndrome, its psychiatric implications and their possible biological basis
    Published on 2024-06-24
    2 years ago
  • Letter to editor about the article “Clinical features in co-occuring obsessive-compulsive disorder and bipolar disorder: A systematic review and meta-analysis” (De Prisco M et al.,2023)
    Published on 2024-06-24
    2 years ago
  • Does the presence of sleep disorders predict response to TMS in depression?
    Published on 2024-06-23
    2 years ago
  • Psychological symptoms after awake deep brain stimulation surgery in parkinson’s disease, essential tremor, and dystonia
    Published on 2024-06-23
    2 years ago
  • GLP-1 receptor agonists: A revolution in the treatment of Parkinson’s disease?
    Published on 2024-06-23
    2 years ago
  • Social dysfunction relates to shifts within socioaffective brain systems among Schizophrenia and Alzheimer’s disease patients
    Published on 2024-06-23
    2 years ago
  • Meta-analyses of pharmacogenetics-guided antidepressant treatment: Reply to milosavljevic
    Published on 2024-06-23
    2 years ago
« Previous 1 … 42 43 44 45 46 … 166 Next »

   Pharma Pub